Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Main Life Corp. is a South Korean biotechnology company specializing in regenerative medicine and bio-convergence technologies. The company focuses on the development of exosome-based therapeutics and advanced medical devices, particularly for dermatological applications such as hair growth stimulation and skin rejuvenation. Their product portfolio includes the Main Life brand of laser-based hair loss treatment devices and exosome-infused cosmeceuticals. Main Life leverages its proprietary exosome extraction and stabilization platforms to target unmet needs in the aesthetics and regenerative health sectors. By integrating biotechnology with medical engineering, the company aims to provide non-invasive and highly effective treatments for androgenetic alopecia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Main Life Corp..